There are many steps that need to be performed in order to assemble an Investigational New Drug (IND) Application. Whether it be consulting with the FDA, using a GxP compliant collaboration platform, or finding a partner, this process is often complex. Despite the numerous steps, it does not have to be an insurmountable goal.
In this webinar, Egnyte’s Life Sciences Director of Product Management, Harith Kesari, reviews 5 key best practices for assembling your IND. With over 20+ years working at the intersection of clinical development, regulatory affairs, and software, Harith identifies specific tips that you can integrate into your workflow today.
In this session, you will learn:
- Structured content authoring methodology
- GxP compliant tools for collaboration
- How to engage with the FDA